Investments (#)
Investments (USD)
Transactions
Recent transactions in the domain of biotechnology (biotech)
| Company | Country | Funding round | Date | |
|---|---|---|---|---|
|
Vivodyne Inc Philadelphia-based biotech that tests its drug candidates on lab-grown human organs. |
United States | Seed USD 38,000,000 (USD 38,000,000) |
22 Nov 2023 |
|
47 Labs Healthcare through neuro-simulation. |
Canada | Pre Seed |
31 Dec 2022 |
|
ValenzaBio Inc antibody for inflammatory eye disease |
Series A USD 70,000,000 |
8 Apr 2021 | |
|
Blossomhill Therapeutics Inc Biotechnology company focused on oncology and autoimmune disorders. |
United States | Series A USD 71,000,000 (USD 71,000,000) |
4 Mar 2021 |
|
Maridose LLC Biotech - Cannabis R&D. We are a US DEA licensed manufacturer of Schedule 1 drugs. |
United States | Pre Seed USD 150,000 (USD 150,000) |
1 Jan 2021 |
|
Perfect Day Inc |
United States | Series C USD 140,000,000 (USD 140,000,000) |
12 Dec 2019 |
|
Quell Therapeutics Ltd Developer of engineered T regulatory cell therapies. |
United Kingdom | Series A GBP 35,000,000 |
29 Mar 2019 |
|
Aquaro Histology Inc Provider of solutions that improve workflow efficiency, section quality, and consistency in the histology laboratory. |
United States | Series A USD 9,810,880 (USD 9,810,880) |
7 Jun 2017 |
|
20n Using AI to predict biochemistry for manufacturing and therapeutics. |
United States | Seed |
31 Dec 2015 |
|
|
3SBio Inc |
IPO HKD 5,510,000,000 (USD 710,680,000) |
5 Jun 2015 | |
|
Verenium Corp Pioneer in the development and commercialization of high-performance enzymes for use in industrial processes |
United States | Acquisition |
20 Sep 2013 |
|
Wyeth Pharmaceuticals |
Acquisition USD 11,850,000,000 (USD 11,850,000,000) at USD 11,850,000,000 (USD 11,850,000,000) valuation. |
1 Apr 2012 | |
|
|
Solazyme Inc Renewable oil and bioproducts company and the leader in algal biotechnology |
United States | Series D |
9 Aug 2010 |
|
|
Verenium Corp Pioneer in the development and commercialization of high-performance enzymes for use in industrial processes |
United States | Acquisition USD 98,300,000 (USD 98,300,000) at USD 98,300,000 (USD 98,300,000) valuation. |
15 Jul 2010 |
|
|
Solazyme Inc Renewable oil and bioproducts company and the leader in algal biotechnology |
United States | Grant |
1 Dec 2009 |
|
|
Solazyme Inc Renewable oil and bioproducts company and the leader in algal biotechnology |
United States | Series D |
1 Jun 2009 |
|
|
Wyeth Pharmaceuticals |
Acquisition USD 68,000,000,000 (USD 68,000,000,000) at USD 68,000,000,000 (USD 68,000,000,000) valuation. |
23 Jan 2009 | |
|
|
Solazyme Inc Renewable oil and bioproducts company and the leader in algal biotechnology |
United States | Series C |
1 Aug 2008 |
|
|
Solazyme Inc Renewable oil and bioproducts company and the leader in algal biotechnology |
United States | Debt |
1 Sep 2007 |
|
|
Solazyme Inc Renewable oil and bioproducts company and the leader in algal biotechnology |
United States | Series B |
1 Mar 2007 |
|
Benchling Inc Unlocking the power of biotech with modern software for modern science. |
United States | Seed |
|
|
|
Benchling Inc Unlocking the power of biotech with modern software for modern science. |
United States | N/A |
|
|
CellVoyant |
United Kingdom | N/A |
|
|
|
CellVoyant |
United Kingdom | N/A |
|
|
|
CellVoyant |
United Kingdom | N/A |
|
|
|
CellVoyant |
United Kingdom | N/A |
Companies
Best funded companies in biotechnology (biotech)
Biotechnology company focused on oncology and autoimmune disorders.
Philadelphia-based biotech that tests its drug candidates on lab-grown human organs.
Provider of solutions that improve workflow efficiency, section quality, and consistency in the histology laboratory.
Biotech - Cannabis R&D. We are a US DEA licensed manufacturer of Schedule 1 drugs.
Biotechnology company developing a new class of therapies for metabolic diseases and disorders.
Renewable oil and bioproducts company and the leader in algal biotechnology
A cutting-edge biotechnology company, employs a revolutionary RNA nanoparticle technology platform called “pRNA”
Biotechnology company focused on developing new products to eliminate bacterial infections.
Elevate Ventures nurtures and develops emerging and existing high-potential businesses into high-performing, Indiana-based companies.
Investors
Top investors in the domain of biotechnology (biotech)
| Investor | Profile | Country | Investments | |
|---|---|---|---|---|
|
Braemar Energy Ventures LLC | Energy venture capital firm. | United States | 3 |
|
Y Combinator LLC | American technology startup accelerator. | United States | 2 |
|
Horizons Ventures | Venture capital firm owned by Hong Kong billionaire Li Ka-shing | Hong Kong SAR China | 2 |
|
Lightspeed Management Co LLC | Multi-stage venture capital firm focused on accelerating disruptive innovations and trends in the enterprise and consumer sectors. | United States | 1 |
|
Telegraph Hill Partners | United States | 1 | |
|
|
Opaleye LP | United States | 1 | |
|
|
Air Street Capital | 1 | ||
|
Healthcare Ventures LLC | Venture capital firm focused on life sciences companies in pre-clinical and early clinical stage. | United States | 1 |
|
Cormorant Asset Management LLC | 1 | ||
|
The Roda Group | United States | 1 | |
|
Khosla Ventures | Venture capital firm founded by Vinod Khosla. | United States | 1 |
|
Charles River Ventures | Independent venture capital firm | United States | 1 |
|
OrbiMed Advisors LLC | American investment firm focused on making public and private investments in the healthcare and biotechnology industries. | United States | 1 |
|
Bunge Ltd | Global agribusiness and food company. | United States | 1 |
|
VantagePoint Capital Partners | Venture capital firm with investments in the cleantech, information technology, and healthcare sectors. | United States | 1 |
|
Decheng Capital | 1 | ||
|
CS Ventures | The corporate venture fund initiative of Canterbury Scientific Ltd. | 1 | |
|
|
CSK Venture Capital Co Ltd | Japan | 1 | |
|
Fidelity Management and Research Co | investment management firm offering mutual funds, brokerage, retirement solutions, and asset management for institutions. | 1 | |
|
Bison Ventures Management Company LLC | Early-stage venture capital firm investing in frontier technology companies that use innovative science and deep technology. | 1 | |
![[node:title] photo](/sites/default/files/styles/icon/public/default_images/icon-person.png?itok=8SSzz6Wf "[node:title] photo"){kind=icon}
|
Randy Haykin | 1 | ||
|
UCL Technology Fund | United Kingdom | 1 | |
|
Harris & Harris Group Inc | Internally managed venture capital company specializing in nanotechnology and microsystems | United States | 1 |
|
|
Golden Pine Ventures LLC | United States | 1 | |
|
Janus Henderson Group PLC | Global asset management group. | United Kingdom | 1 |
|
Octopus Ventures Ltd | United Kingdom | 1 | |
|
|
Keating Capital Inc | Business development company that specializes in making pre-IPO investments in innovative, high growth private companies | United States | 1 |
|
Morgan Stanley & Co Inc | Investment bank | United States | 1 |
|
Foreword Ventures | Early-stage technology fund that invests in and supports companies throughout their initial chapters. | 1 | |
|
Entrepreneur First Investment Manager LLP | Tehnology incubator that invests in individuals “pre-team, pre-idea” to help create new technology startups. | United Kingdom | 1 |
|
Rho Capital Partners | Venture capital firm that actively invests in companies related to technology, new media, cleaning technology and healthcare. | United States | 1 |
|
|
Hercules BioVentures | 1 | ||
|
|
San-Ei Gen FFI Inc | Major Japanese manufacturer and distributor of food ingredients | United Kingdom | 1 |
|
SNR Ventures Management LP | 1 | ||
|
Kairos Venture Investments LLC | Venture capital firm. | United States | 1 |
|
Apax Partners | United Kingdom | 1 | |
|
Vivo Capital LLC | 1 | ||
|
Chevron Technology Ventures LLC | Corporate venturing subsidiary of ChevronTexaco, focusing on the commercialisation and integration of emerging technologies within Chevron | United States | 1 |
|
Zygote Ventures LLC | Privately held seed/angel venture capital fund | United States | 1 |
|
|
Syncona Investment Management Ltd | 1 | ||
|
MBX Capital LLC | Venture capital partnership focused on emerging companies pursuing critical challenges in public health. | United States | 1 |
|
|
New York Life Capital Partners LLC | United States | 1 | |
|
|
Ikarian Healthcare Fund LP | United States | 1 | |
|
|
CTTV Investments LLC | The venture capital arm of Chevron Technology Ventures LLC | United States | 1 |
|
Verve Capital Partners AG | Switzerland | 1 | |
|
Unilever Ventures Ltd | United Kingdom | 1 | |
|
Temasek Holdings (Pte) Ltd | Singapore's sovereign wealth fund. | Singapore | 1 |
Acquirers
Top acquirers in the domain of biotechnology (biotech)
| Investor | Profile | Country | Acquisitions | |
|---|---|---|---|---|
|
BP Biofuels North America | 1 | ||
|
Pfizer Inc | United States | 1 | |
|
BASF SE | Germany | 1 | |
|
Nestlé SA | Switzerland | 1 |